Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients
Table 2
Evaluation of articulation organ functions by FDA in 32 ALS patients divided into 3 groups (I—improved articulation, II—lack of improvement, and III—deteriorated articulation), measured 7 and 28 days after Lin− cell administration compared to the baseline values (day 0).